Volume | 1,825,440 |
|
|||||
News | - | ||||||
Day High | 88.14 | Low High |
|||||
Day Low | 86.95 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Edwards Lifesciences Corp | EW | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
87.92 | 86.95 | 88.14 | 87.41 | 87.86 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
31,075 | 1,825,440 | US$ 87.52 | US$ 159,759,185 | - | 60.57 - 96.12 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:52:24 | 10 | US$ 87.50 | USD |
Edwards Lifesciences Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
52.52B | 601.30M | - | 6B | 1.4B | 2.33 | 37.45 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Edwards Lifesciences News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EW Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 87.80 | 88.855 | 85.79 | 87.28 | 2,844,372 | -0.80 | -0.91% |
1 Month | 85.60 | 91.94 | 84.67 | 87.79 | 2,416,298 | 1.40 | 1.64% |
3 Months | 90.58 | 96.12 | 83.50 | 89.92 | 2,982,761 | -3.58 | -3.95% |
6 Months | 68.36 | 96.12 | 66.86 | 83.45 | 3,731,992 | 18.64 | 27.27% |
1 Year | 84.94 | 96.12 | 60.57 | 79.42 | 3,716,197 | 2.06 | 2.43% |
3 Years | 94.76 | 131.73 | 60.57 | 88.71 | 3,233,807 | -7.76 | -8.19% |
5 Years | 170.44 | 248.50 | 60.57 | 99.65 | 2,732,541 | -83.44 | -48.96% |
Edwards Lifesciences Description
Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology serving patients in 100+ countries with the help of our employees in areas including Clinical Affairs Quality Engineering Research & Development Regulatory Affairs Sales & Marketing corporate functions and more. Our roots date back to 1958 when Miles Lowell Edwards a retired engineer with a background in hydraulics and fuel pump operations set out to build the first artificial heart. Edwards believed the heart could be mechanized and was encouraged by Dr. Albert Starr to focus on developing an artificial heart valve. After just two years the first Starr-Edwards mitral valve was developed and successfully placed in a patient. This innovation spawned Edwards Laboratories. |